W
WSI Co Ltd
KOSDAQ:299170
WSI Co Ltd
KOSDAQ:299170
Price:
3 210
KRW
Market Closed
Market Cap:
₩133.2B
WSI Co Ltd
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
WSI Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
Research & Development
-₩653.3m
|
CAGR 3-Years
-86%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Chorokbaem Healthcare Co Ltd
KRX:118000
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
Research & Development
-₩1.5B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Life Science Co Ltd
KOSDAQ:067630
|
Research & Development
-₩5.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-56%
|
|
|
B
|
BlueMTec Co Ltd
KOSDAQ:439580
|
Research & Development
-₩1.3B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
WSI Co Ltd
Glance View
WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
WSI Co Ltd Intrinsic Value
HIDDEN
See Also
What is WSI Co Ltd's Research & Development?
Research & Development
-653.3m
KRW
-653.3m
KRW
Based on the financial report for Dec 31, 2024, WSI Co Ltd's Research & Development amounts to -653.3m KRW.
What is WSI Co Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-86%
-86%
Over the last year, the Research & Development growth was -265%. The average annual Research & Development growth rates for WSI Co Ltd have been -86% over the past three years .
